Disc Medicine's market cap is currently $2.28B. The company's EPS TTM is $-1.58; its P/E ratio is ―; Disc Medicine is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $-1.48. See an overview of income statement, balance sheet, and cash flow financials.
